Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration-Reference-Cited by-同舟云学术

Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration

Published:2015-12 Issue:15 Volume:8 Page:1990-1999
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Yetgin Tuncay,Uitterdijk André,te Lintel Hekkert Maaike,Merkus Daphne,Krabbendam-Peters Ilona,van Beusekom Heleen M.M.,Falotico Robert,Serruys Patrick W.,Manintveld Olivier C.,van Geuns Robert-Jan M.,Zijlstra Felix,Duncker Dirk J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;Steg;Eur Heart J,2012

2. Myocardial reperfusion: a double-edged sword?;Braunwald;J Clin Invest,1985

3. Myocardial reperfusion injury;Yellon;N Engl J Med,2007

4. The “no-reflow” phenomenon after temporary coronary occlusion in the dog;Kloner;J Clin Invest,1974

5. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction;Ndrepepa;J Am Coll Cardiol,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined intracoronary nitroprusside infusion during prolonged perfusion balloon inflation for ST-segment elevation myocardial infarction;European Heart Journal - Case Reports;2023-12-01

2. Accumulation of endogenous adenosine improves cardiomyocyte metabolism via epigenetic reprogramming in an ischemia-reperfusion model;Redox Biology;2023-11

3. Sex Differences in Therapies against Myocardial Ischemia-Reperfusion Injury: From Basic Science to Clinical Perspectives;Cells;2023-08-16

4. Hydrogel delivery of purinergic enzymes improves cardiac ischemia/reperfusion injury;Journal of Molecular and Cellular Cardiology;2023-03

5. No-Reflow After Primary PCI: Will Distal Intracoronary Medication Do the Trick?;Cardiovascular Revascularization Medicine;2023-02